The discovery of mutations in the BCMA ectodomain and GPRC5D that differentially attenuate CAR T/TCE binding to their cognate epitope, precipitating MM disease relapse, highlights the critical relevance of screening for these variants. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.